Impact of obesity on bone metabolism;Influencia de la obesidad sobre el metabolismo óseo

Endocrinologia y Nutricion

Volumn 63, Issue 10, 2016, Pages 551-559

  López Gómez, Juan J ^a,b   Pérez Castrillón, José L ^b,c   de Luis Román, Daniel A ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b Inst de Endocrinologia y Nutricion   (Spain)

^c HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Adypocytokines; Bone turnover; Obesity; Vitamin D

Indexed keywords

BODY COMPOSITION; BODY WEIGHT; BONE DISEASE; BONE MASS; BONE METABOLISM; DIET; FRACTURE; HUMAN; OBESITY; SHORT SURVEY; ADIPOSE TISSUE; BONE; BONE DENSITY; COMPLICATION; DISEASE PREDISPOSITION; INSULIN RESISTANCE; METABOLISM; OSTEOPOROSIS; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; SARCOPENIA; SECONDARY HYPERPARATHYROIDISM;

ADIPOCYTOKINE; CALCIUM; HORMONE; PHOSPHORUS;

ADIPOKINES; ADIPOSE TISSUE; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; CALCIUM; DISEASE SUSCEPTIBILITY; FRACTURES, BONE; HORMONES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INSULIN RESISTANCE; OBESITY; OSTEOPOROSIS; PHOSPHORUS; RISK FACTORS; SARCOPENIA;

EID: 84996548911     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2016.08.005     Document Type: Short Survey

References (68)

1. 1 Ström, O., Borgström, F., Kanis, J.A., Compston, J., Cooper, C., McCloskey, E., et al. Osteoporosis: Burden, health care provision and opportunities in the EU: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 6 (2011), 59–155.
2. 2 Hernlund, E., Svedbom, A., Ivergård, M., Compston, J., Cooper, C., Stenmark, J., et al. Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos., 8, 2013, 136.
3. 3 Finucane, M.M., Stevens, G.A., Cowan, M.J., Daniel, G., Lin, J.K., Paciorek, C.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9,1 million participants. Lancet 377 (2011), 557–567.
4. 4 Gutiérrez-Fisac, J.L., Guallar-Castillón, P., León-Muñoz, L.M., Graciani, A., Banegas, J.R., Rodríguez-Artalejo, F., Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: The ENRICA study. Obes rev 13 (2012), 388–392.
5. 5 De Laet, C., Kanis, J.A., Odén, A., Johanson, H., Johnell, O., Delmas, P., et al. Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos Int 16 (2005), 1330–1338.
6. 6 Johansson, H., Kanis, J.A., Oden, A., McCloskey, E., Chapurlat, R.D., Christiansen, C., A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res. 29 (2014), 223–233.
7. 7 Caffarelli, C., Alessi, C., Nuti, R., Gonnelli, S., Divergent effects of obesity on fragility fractures. Clin Interv Aging. 9 (2014), 1629–1636.
8. 8 Compston, J.E., Watts, N.B., Chapurlat, R., Cooper, C., Boonen, S., Greenspan, S., et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med. 124 (2011), 1043–1050.
9. 9 Shapses, S.A., Sukumar, D., Bone metabolism in obesity and weight loss. Annu Rev Nutr. 32 (2012), 287–309.
10. 10 Ho-Pham, L.T., Nguyen, U.D., Nguyen, T.V., Association between lean mass, fat mass, and bone mineral density: A meta-analysis. J Clin Endocrinol Metab. 99 (2014), 30–38.
11. 11 Scott, D., Chandrasekara, S.D., Laslett, L.L., Cicuttini, F., Ebeling, P.R., Jones, G., Associations of sarcopenic obesity and dynapenic obesity with bone mineral density and incident fractures over 5-10 years in community dwelling older adults. Calcif Tissue Int. 99 (2016), 30–42.
12. 12 Neubecker, K., Fazeli, P., Lawson, E., Russell, B., Riccio, A., Meenaghan, E., Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women. J Clin Endocrinol Metab. 99 (2014), 4664–4673.
13. 13 Cauley, J.A., An overview of sarcopenic obesity. J Clin Densitom. 18 (2015), 499–505.
14. 14 Jensen, G.L., Ying Hsiao, P., Obesity in older adults: Relationship to functional limitation. Curr Opin Clin Nutr Metab Care. 13 (2012), 46–51.
15. 15 Gower, B., Casazza, K., Divergent effects of obesity on bone health. J Clin Densitom. 16 (2013), 450–454.
16. 16 Moayyeri, A., Luben, R.N., Wareham, N.J., Khaw, K.T., Body fat mass is a predictor of risk of osteoporotic fractures in women but not in men: A prospective population study. J Intern Med. 271 (2012), 472–480.
17. 17 Holecki, M., Wiecek, A., Relationship between body fat mass and bone metabolism. Pol Arch Med Wewn. 120 (2010), 361–367.
18. 18 Sheu, Y., Cauley, J., The role of bone marrow and visceral fat on bone metabolism. Curr Osteoporos Rep. 9 (2014), 67–75.
19. 19 Cornish, J., Callon, K.E., Bava, U., Lin, C., Naot, D., Hill, B.L., et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 175 (2002), 405–415.
20. 20 Elefteriou, F., Ahn, J.D., Takeda, S., Starbuck, M., Yang, X.L., Liu, X.Y., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434 (2005), 514–520.
21. 21 Prouteau, S., Berthamou, L., Courteix, D., Relationships between serum leptin and bone markers during stable weight, weight reduction and weight regain in male and female judoists. Eur J Endocrinol. 154 (2006), 389–395.
22. 22 Biver, E., Salliot, C., Combescure, C., Gossec, L., Hardouin, P., Legroux-Gerot, I., et al. Influence of adipokines and ghrelin on bone mineral density and fracture risk: A systematic review and meta-analysis. J Clin Endocrinol Metab. 96 (2011), 2703–2713.
23. 23 Upadhyay, J., Farr, O.M., Mantzoros, S., The role of leptin in regulating bone metabolism. Metabolism. 64 (2015), 105–113.
24. 24 Conroy, R., Girotra, M., Shane, E., McMahon, D.J., Pavlovich, K.H., Leibel, R.L., Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism. 60 (2011), 1222–1226.
25. 25 Luo, X.H., Guo, L.J., Xie, H., Yuan, L.Q., Wu, X.P., Zhou, H.D., et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res. 21 (2006), 1648–1656.
26. 26 Vilarrasa, N., Gómez, J.M., Masdevall, C., Pujol, J., Soler, J., Elio, I., et al. Study of the relationship between adiponectin, interleukin-18, ghrelin and bone mineral density in morbidly obese women after gastric bypass. Endocrinol Nutr. 56 (2009), 355–360.
27. 27 Ostrowska, Z., Ziora, K., Oswiecimska, J., Swietochowska, E., Marek, B., Kajdaniuk, D., et al. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-kB ligand and selected adipose tissue hormones in girls with anorexia nervosa. Endokrynol Pol. 65 (2014), 33–39.
28. 28 Van der Lely, A., Tschop, M., Heiman, M., Ghigo, E., Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 25 (2013), 426–457.
29. 29 Soeki, T., Kishimoto, I., Schwenke, D., Tokudome, T., Horio, T., Yoshida, M., et al. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol. 294 (2007), H426–H432.
30. 30 Makovey, J., Naganathan, V., Seibel, M., Sambrook, P., Gender differences in plasma ghrelin and its relations to body composition and bone – an opposite sex twin study. Clin Endocrinol (Oxf). 66 (2007), 530–537.
31. 31 Misra, M., Millar, K., Stewart, V., Hunter, E., Kuo, K., Hergoz, D.B., et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol. 90 (2005), 5082–5087.
32. 32 Cao, J.J., Effects of obesity on bone metabolism. J Orthop Surg Res. 6 (2011), 30–37.
33. 33 Greco, E.A., Lenzi, A., Migliaccio, S., The obesity of bone. Ther Adv Endocrinol Metab. 6 (2015), 273–286.
34. 34 Dodds, A., Merry, K., Littlewood, A., Gowen, M., Expression of mRNA for IL1 beta, IL6 and TGF beta 1 in developing human bone and cartilage. J Histochem Cytochem. 42 (1994), 733–744.
35. 35 Sims, N., Jenkins, B., Quinn, J., Nakamura, A., Glatt, M., Gillespie, M., et al. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest. 113 (2004), 379–389.
36. 36 Jules, J., Wang, S., Shi, Z., Liu, J., Wei, S., Feng, X., The IVVY motif and tumor necrosis factor receptor-associated factor (TRAF) sites in the cytoplasmic domain of the receptor activator of nuclear factor kB (RANK) cooperate to induce osteoclastogenesis. J Biol Chem. 290 (2015), 23738–23750.
37. 37 Corina, M., Vulpoi, C., Branisteanu, D., Relationship between bone mineral density, weight, and estrogen levels in pre and postmenopausal women. Rev Med Chir Soc Med Nat lasi. 116 (2012), 946–950.
38. 38 Cenci, S., Weitzmann, M., Roggia, C., Namba, N., Novack, D., Woodring, J., et al. Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: A transiliac bone biopsy Study. J Clin Endocrinol Metab. 98 (2013), 256–272.
39. 39 Choi, H.S., Kim, K.J., Kim, K.M., Hur, N.W., Rhee, Y., Han, D.S., et al. Relationship between visceral adiposity and bone mineral density in Korean adults. Calcif Tissue Int. 87 (2010), 218–225.
40. 40 Gilsanz, V., Chalfant, J., Mo, A.O., Lee, D.C., Dorey, F.J., Mittelman, S.D., Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab. 94 (2009), 3387–3393.
41. 41 Schellinger, D., Lin, C.S., Lim, J., Hatipoglu, H.G., Pezzullo, J.C., Singer, A.J., Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: Their ratio as a new indicator of bone weakening. AJR Am J Roentgenol. 183 (2004), 1761–1765.
42. 42 Paccou, J., Hardouin, P., Cotten, A., Penel, G., Cortet, B., The role of bone marrow fat in skeletal Health: Usefulness and perspectives for clinicians. J Clin Endocrinol Metab. 100 (2015), 3613–3621.
43. 43 Aguirre, L., Napoli, N., Waters, D., Qualls, C., Villareal, D.T., Armamento-Villareal, R., Increasing adiposity is associated with higher adipokine levels and lower bone mineral density in obese older adults. J Clin Endocrinol Metab. 99 (2014), 3290–3297.
44. 44 Zhao, L.J., Jiang, H., Papasian, C.J., Maulik, D., Drees, B., Hamilton, J., et al. Correlation of obesity and osteoporosis: Effect of fat mass on the determination of osteoporosis. J Bone Miner Res. 23 (2008), 17–29.
45. 45 Vestergaard, P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis. Osteoporos Int. 18 (2007), 427–444.
46. 46 Naot, D., Cornish, J., The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone. 43 (2008), 813–818.
47. 47 Bosetti, M., Sabbatini, M., Nicoli, E., Fusaro, L., Cannas, M., Effects and differentiation activity of IGF-I, IGF-II, insulin and preptin on human primary bone cells. Growth Factors. 31 (2013), 57–65.
48. 48 Ferron, M., Hinoi, E., Karsenty, G., Ducy, P., Ostecalcin differentially regulates beta-cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Pro Natl Acad Sci U S A 105 (2008), 5266–5270.
49. 49 Zanatta, L.C., Boguszewski, Borba, V.Z., Kulak, C.A., Osteocalcin, energy and glucose metabolism. Arq Bras Endocrinol Metab. 58 (2014), 444–451.
50. 50 Bador, K.M., Wee, L.D., Halim, S.A., Fadi, M.F., Santhiran, P., Rosli, N.F., et al. Serum osteocalcin in subjects with metabolic syndrome and central obesity. Diabetes Metab Syndr. 10:Suppl 1 (2016), S42–S45.
51. 51 Cândido, F.G., Bressan, J., Vitamin D: Link between osteoporosis, obesity and diabetes. Int J Mol Sci. 15 (2014), 6569–6591.
52. 52 Calatayud, M., Jódar, E., Sánchez, R., Guadalix, S., Hawkins, F., Prevalence of deficient and insufficient vitamin D levels in a young healthy population. Endocrinol Nutr. 56 (2009), 164–169.
53. 53 Bruyère, O., Malaise, O., Neuprez, A., Collette, J., Reginster, J.Y., Prevalence of vitamin D inadequacy in European postmenopausal women. Curr Med Res Opin. 23 (2007), 1939–1944.
54. 54 Gallagher, J.C., Yalamanchili, V., Smith, L.M., The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J Steroid Biochem Mol Biol. 136 (2013), 195–200.
55. 55 Censani M, Stein EM, Shane E, Oberfield SE, McMahon DJ, Lerner S, et al. Vitamin D deficiency is prevalent in morbidly obese adolescents prior to bariatric surgery. ISRN Obes. 2013; 2013 pii: 284516. doi: 10.1155/2013/284516.
56. 56 Wortsman, J., Matsuoka, L.Y., Chen, T.C., Lu, Z., Holick, M.F., Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 72 (2000), 690–693.
57. 57 Eliades, M., Spyrou, E., Agrawal, N., Lazo, M., Brancati, F.L., Potter, J.J., et al. Meta-analysis: Vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 38 (2013), 246–254.
58. 58 Diehl, J.W., Chiu, M.W., Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol Ther. 23 (2010), 48–60.
59. 59 Wamberg, L., Pedersen, S.B., Rejnmark, L., Richelsen, B., Causes of vitamin D deficiency and effect of vitamin D supplementation on metabolic complications in obesity: A review. Curr Obes Rep. 4 (2015), 429–440.
60. 60 Sukumar, D., Schlussel, Y., Riedt, C.S., Gordon, C., Stahl, T., Shapses, S.A., Obesity alters cortical and trabecular bone density and geometry in women. Osteoporos Int. 22 (2011), 635–640.
61. 61 González-Campoy, J., St Jeor, S.T., Castorino, K., Ebrahim, A., Hurley, D., Jovanovic, L., et al. Clinical Practice Guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: Cosponsored by the American association of clinical endocrinologists/The American College of Endocrinology and The Obesity Society. Endocr Pract. 19:Suppl 3 (2013), 1–82.
62. 62 SENC. Objetivos nutricionales para la población española. Consenso de la Sociedad Española de Nutrición Comunitaria 2011. Rev Esp Nutr Com 17 (2011), 178–199.
63. 63 Bischoff-Ferrari, H.A., Giovanucci, E., Willet, W.C., Dietrich, T., Dawson-Hughes, B., Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 84 (2006), 18–28.
64. 64 Drincic, A., Fuller, E., Heaney, R.P., Armas, L.A., 25-hydroxyvitamin D response to graded vitamin D3 supplementation among obese adults. J Clin Endocrinol Metab. 98 (2013), 4845–4851.
65. 65 Rodríguez-Rodríguez, E., Navia Lombán, López-Sobaler, A.M., Ortega Anta, M., Review and future perspectives on recommended calcium intake. Nutr Hosp. 25 (2010), 366–374.
66. 66 Shapses, S.A., Sukumar, D., Schneider, S.H., Schlussel, Y., Brolin, R.E., Taich, L., Hormonal and dietary influences on true fractional calcium absorption in women: Role of obesity. Osteoporos Int. 23 (2012), 2607–2614.
67. 67 Varela-Moreiras, G., Ruiz, E., Valero, T., Avila, J.M., del Pozo, S., The Spanish diet: An update. Nutr Hosp.(Suppl 5), 2013, 13–20.
68. 68 Calvo, M.S., Tucker, K.L., Is phosphorus intake that exceeds dietary requirements a risk factor in bone health?. Ann Y Acad Sci. 1301 (2013), 29–35.